CD8A and neoplasm: The blockade of p38 MAPK signalling was observed to decrease M‐MDSC infiltration in the liver, which showed a positive correlation with the proportion of CD8+ T cells and a negative association with tumour mass, thus inhibiting the progression of hepatocellular carcinoma.42